Impel Pharmaceuticals (IMPL) Q4 2022 Earnings

Mar 24Confirmed
May 2022
Aug 2022
Nov 2022
Q4 2022
-1.31
-1.2
-1.08
-0.97

Details

Expected EPS
-1.11
Actual EPS
-0.97
Surprise EPS
0.14
Surprise Percent
+12.61%

Description

⁨Impel Pharmaceuticals⁩ (⁦IMPL⁩) has reported earnings of ⁦-0.97⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts